383 related articles for article (PubMed ID: 25598673)
1. Integrated whole body MR/PET: where are we?
Yoo HJ; Lee JS; Lee JM
Korean J Radiol; 2015; 16(1):32-49. PubMed ID: 25598673
[TBL] [Abstract][Full Text] [Related]
2. MR/PET: a new challenge in hybrid imaging.
Werner MK; Schmidt H; Schwenzer NF
AJR Am J Roentgenol; 2012 Aug; 199(2):272-7. PubMed ID: 22826387
[TBL] [Abstract][Full Text] [Related]
3. Integrated whole-body PET/MR hybrid imaging: clinical experience.
Quick HH; von Gall C; Zeilinger M; Wiesmüller M; Braun H; Ziegler S; Kuwert T; Uder M; Dörfler A; Kalender WA; Lell M
Invest Radiol; 2013 May; 48(5):280-9. PubMed ID: 23442775
[TBL] [Abstract][Full Text] [Related]
4. Integrated PET/MR.
Quick HH
J Magn Reson Imaging; 2014 Feb; 39(2):243-58. PubMed ID: 24338921
[TBL] [Abstract][Full Text] [Related]
5. [Whole-body MRI and FDG-PET/CT imaging diagnostics in oncology].
Schmidt GP; Haug A; Reiser MF; Rist C
Radiologe; 2010 Apr; 50(4):329-38. PubMed ID: 20229091
[TBL] [Abstract][Full Text] [Related]
6. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients.
Ohno Y; Koyama H; Yoshikawa T; Takenaka D; Seki S; Yui M; Yamagata H; Aoyagi K; Matsumoto S; Sugimura K
Radiology; 2015 Jun; 275(3):849-61. PubMed ID: 25584709
[TBL] [Abstract][Full Text] [Related]
7. Pulmonary lesion assessment: comparison of whole-body hybrid MR/PET and PET/CT imaging--pilot study.
Schwenzer NF; Schraml C; Müller M; Brendle C; Sauter A; Spengler W; Pfannenberg AC; Claussen CD; Schmidt H
Radiology; 2012 Aug; 264(2):551-8. PubMed ID: 22653189
[TBL] [Abstract][Full Text] [Related]
8. Performance of whole-body integrated 18F-FDG PET/MR in comparison to PET/CT for evaluation of malignant bone lesions.
Eiber M; Takei T; Souvatzoglou M; Mayerhoefer ME; Fürst S; Gaertner FC; Loeffelbein DJ; Rummeny EJ; Ziegler SI; Schwaiger M; Beer AJ
J Nucl Med; 2014 Feb; 55(2):191-7. PubMed ID: 24309383
[TBL] [Abstract][Full Text] [Related]
9. Clinical Applications of PET/MR Imaging.
Moradi F; Iagaru A; McConathy J
Radiol Clin North Am; 2021 Sep; 59(5):853-874. PubMed ID: 34392923
[TBL] [Abstract][Full Text] [Related]
10. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
[TBL] [Abstract][Full Text] [Related]
11. PET/MRI with diagnostic MR sequences vs PET/CT in the detection of abdominal and pelvic cancer.
Xin J; Ma Q; Guo Q; Sun H; Zhang S; Liu C; Zhai W
Eur J Radiol; 2016 Apr; 85(4):751-9. PubMed ID: 26971419
[TBL] [Abstract][Full Text] [Related]
12. Whole-body nonenhanced PET/MR versus PET/CT in the staging and restaging of cancers: preliminary observations.
Huellner MW; Appenzeller P; Kuhn FP; Husmann L; Pietsch CM; Burger IA; Porto M; Delso G; von Schulthess GK; Veit-Haibach P
Radiology; 2014 Dec; 273(3):859-69. PubMed ID: 25102372
[TBL] [Abstract][Full Text] [Related]
13. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
14. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
15. Hybrid PET/MR imaging: physics and technical considerations.
Shah SN; Huang SS
Abdom Imaging; 2015 Aug; 40(6):1358-65. PubMed ID: 25985965
[TBL] [Abstract][Full Text] [Related]
16. Whole-Body MR Imaging: The Novel, "Intrinsically Hybrid," Approach to Metastases, Myeloma, Lymphoma, in Bones and Beyond.
Lecouvet FE; Van Nieuwenhove S; Jamar F; Lhommel R; Guermazi A; Pasoglou VP
PET Clin; 2018 Oct; 13(4):505-522. PubMed ID: 30219185
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer staging: comparison of whole-body PET/CT and PET/MR.
Catalano OA; Coutinho AM; Sahani DV; Vangel MG; Gee MS; Hahn PF; Witzel T; Soricelli A; Salvatore M; Catana C; Mahmood U; Rosen BR; Gervais D
Abdom Radiol (NY); 2017 Apr; 42(4):1141-1151. PubMed ID: 27891551
[TBL] [Abstract][Full Text] [Related]
18. Implementation and performance evaluation of simultaneous PET/MR whole-body imaging with continuous table motion.
Braun H; Ziegler S; Lentschig MG; Quick HH
J Nucl Med; 2014 Jan; 55(1):161-8. PubMed ID: 24232869
[TBL] [Abstract][Full Text] [Related]
19. First clinical experience with integrated whole-body PET/MR: comparison to PET/CT in patients with oncologic diagnoses.
Drzezga A; Souvatzoglou M; Eiber M; Beer AJ; Fürst S; Martinez-Möller A; Nekolla SG; Ziegler S; Ganter C; Rummeny EJ; Schwaiger M
J Nucl Med; 2012 Jun; 53(6):845-55. PubMed ID: 22534830
[TBL] [Abstract][Full Text] [Related]
20. Whole-body PET/MRI for colorectal cancer staging: Is it the way forward?
Lee DH; Lee JM
J Magn Reson Imaging; 2017 Jan; 45(1):21-35. PubMed ID: 27346172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
